Showing results (341-350 of 390) with videos related to

Sort By:
Pageof 39
Journal of Inherited Metabolic Disease|April 24, 2009
The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell linesE R Benjamin, J J Flanagan, A Schilling, et al.
DNA Repair|April 25, 2022
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombinationChristopher Parker, Adam C Chambers, Dustin J Flanagan, et al.
Current Pain and Headache Reports|August 9, 2023
Cebranopadol for the Treatment of Chronic PainAmber N Edinoff, Chelsi J Flanagan, Logan T Roberts, et al.
Prehospital and Disaster Medicine|May 23, 2001
Telehealth and communication technologies in health: summary and action planS Braham, P Brownsword, H Delooz, et al.
Molecules (Basel, Switzerland)|February 15, 2020
Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted BenzimidazolesHeba T Abdel-Mohsen, Mona A Abdullaziz, Ahmed M El Kerdawy, et al.
The Journal of Infectious Diseases|September 8, 2021
Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 TrialAnita Boyapati, Matthew F Wipperman, Peter J Ehmann, et al.
Cureus|January 29, 2024
Clostridioides difficile Infection: A Clinical Review of Pathogenesis, Clinical Considerations, and Treatment StrategiesEvan S Sinnathamby, Joseph W Mason, Chelsi J Flanagan, et al.
Cureus|March 22, 2024
Fluoroquinolones: Neurological Complications and Side Effects in Clinical PracticeAhmed I Anwar, Lei Lu, Connor J Plaisance, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 13, 2011
Intestinal epithelial-specific PTEN inactivation results in tumor formationDo-Sun Byun, Naseem Ahmed, Shannon Nasser, et al.
The Journal of Clinical Investigation|July 1, 1997
Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid jointsM W Lark, E K Bayne, J Flanagan, et al.
Pageof 39